id stringlengths 11 11 | tags stringlengths 10 777 | text stringlengths 2 1.5k | dataset_num int64 1 3 | tokens list | ner_tags list |
|---|---|---|---|---|---|
NCT02473536 | 15:33:cancer | Any number of metastatic disease is allowed in the Pilot phase of the trial | 2 | [
"Any",
"number",
"of",
"metastatic",
"disease",
"is",
"allowed",
"in",
"the",
"Pilot",
"phase",
"of",
"the",
"trial"
] | [
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02995590 | 12:14:chronic_disease,16:22:chronic_disease,48:60:chronic_disease | History of MI, stroke and/or poorly controlled hypertension | 2 | [
"History",
"of",
"MI",
",",
"stroke",
"and/or",
"poorly",
"controlled",
"hypertension"
] | [
0,
0,
2,
0,
2,
0,
0,
0,
2
] |
NCT02547818 | 41:67:treatment | Visual and auditory acuity adequate for neuropsychological testing | 2 | [
"Visual",
"and",
"auditory",
"acuity",
"adequate",
"for",
"neuropsychological",
"testing"
] | [
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02587936 | 1:16:chronic_disease | Type 2 diabetes included in problem list | 2 | [
"Type",
"2",
"diabetes",
"included",
"in",
"problem",
"list"
] | [
2,
2,
2,
0,
0,
0,
0
] |
NCT02521818 | 52:72:chronic_disease | availability of cohabitating study partner without cognitive impairment | 2 | [
"availability",
"of",
"cohabitating",
"study",
"partner",
"without",
"cognitive",
"impairment"
] | [
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02418195 | 1:33:chronic_disease | Pervasive developmental disorder | 2 | [
"Pervasive",
"developmental",
"disorder"
] | [
2,
2,
2
] |
NCT02172950 | ,,,,62:85:chronic_disease,,,, | Males 0 to <65 years age who have been diagnosed with severe congenital hemophilia A (FVIII activity levels < 1%), who have at least 50 EDs to any FVIII product, and who are not currently enrolled in a CSL-sponsored clinical study with rVIII-SingleChain | 2 | [
"Males",
"0",
"to",
"<",
"65",
"years",
"age",
"who",
"have",
"been",
"diagnosed",
"with",
"severe",
"congenital",
"hemophilia",
"A",
"(",
"FVIII",
"activity",
"levels",
"<",
"1",
"%",
")",
",",
"who",
"have",
"at",
"least",
"50",
"EDs",
"to",
"any",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01994538 | 1:10:treatment,29:58:treatment | Treatment initiated with an empiric antimicrobial regimen that is underdosed, based on current guidelines and reviews | 2 | [
"Treatment",
"initiated",
"with",
"an",
"empiric",
"antimicrobial",
"regimen",
"that",
"is",
"underdosed",
",",
"based",
"on",
"current",
"guidelines",
"and",
"reviews"
] | [
1,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02607748 | 1:17:chronic_disease,56:88:treatment,,148:151:chronic_disease,, | Asymptomatic CAD group: 40 patients who have undergone Coronary Artery Calcium scanning within 6 months prior to the imaging visit, matched to the ACS patients for age, gender, and CAC score | 2 | [
"Asymptomatic",
"CAD",
"group",
":",
"40",
"patients",
"who",
"have",
"undergone",
"Coronary",
"Artery",
"Calcium",
"scanning",
"within",
"6",
"months",
"prior",
"to",
"the",
"imaging",
"visit",
",",
"matched",
"to",
"the",
"ACS",
"patients",
"for",
"age",
"... | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02578732 | 15:33:cancer | Patients with metastatic disease | 2 | [
"Patients",
"with",
"metastatic",
"disease"
] | [
0,
0,
3,
3
] |
NCT02548351 | 1:16:chronic_disease | Type 2 diabetes diagnosed per 2013 American Diabetes Association criteria | 2 | [
"Type",
"2",
"diabetes",
"diagnosed",
"per",
"2013",
"American",
"Diabetes",
"Association",
"criteria"
] | [
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02519322 | 26:37:chronic_disease | Subjects with history of myocarditis, regardless of etiology | 2 | [
"Subjects",
"with",
"history",
"of",
"myocarditis",
",",
"regardless",
"of",
"etiology"
] | [
0,
0,
0,
0,
2,
0,
0,
0,
0
] |
NCT02213289 | 12:30:cancer | Measurable metastatic disease | 2 | [
"Measurable",
"metastatic",
"disease"
] | [
0,
3,
3
] |
NCT02664168 | 48:86:treatment | Skin integrity issues that preclude the use of Negative Pressure Wound Therapy (NPWT) | 2 | [
"Skin",
"integrity",
"issues",
"that",
"preclude",
"the",
"use",
"of",
"Negative",
"Pressure",
"Wound",
"Therapy",
"(",
"NPWT",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0
] |
NCT02159703 | 13:15:chronic_disease,19:29:chronic_disease,33:48:treatment | Presence of N0 or N1 disease in neck dissection | 2 | [
"Presence",
"of",
"N0",
"or",
"N1",
"disease",
"in",
"neck",
"dissection"
] | [
0,
0,
2,
0,
2,
2,
0,
1,
1
] |
NCT02489045 | 15:44:chronic_disease | Patients with respiratory distress syndrome | 2 | [
"Patients",
"with",
"respiratory",
"distress",
"syndrome"
] | [
0,
0,
2,
2,
2
] |
NCT02669030 | 14:28:treatment | Currently on antidepressant | 2 | [
"Currently",
"on",
"antidepressant"
] | [
0,
0,
1
] |
NCT02521818 | 1:14:allergy_name | multiple food allergies | 2 | [
"multiple",
"food",
"allergies"
] | [
4,
4,
0
] |
NCT02353728 | 12:27:chronic_disease, | History of unstable angina within 1 year of study entry | 2 | [
"History",
"of",
"unstable",
"angina",
"within",
"1",
"year",
"of",
"study",
"entry"
] | [
0,
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02570854 | 12:23:chronic_disease | A positive Hepatitis B surface antigen test result | 2 | [
"A",
"positive",
"Hepatitis",
"B",
"surface",
"antigen",
"test",
"result"
] | [
0,
0,
2,
2,
0,
0,
0,
0
] |
NCT02589977 | 34:36:chronic_disease | physician-confirmed diagnosis of HF | 2 | [
"physician-confirmed",
"diagnosis",
"of",
"HF"
] | [
0,
0,
0,
2
] |
NCT00285935 | 11:30:treatment,88:95:treatment,99:110:treatment,138:157:treatment,161:169:treatment | Taking no medication or drugs likely to interfere with the study objectives (including statins or medications that affect hormones [e.g. birth control pills or steroids]) | 2 | [
"Taking",
"no",
"medication",
"or",
"drugs",
"likely",
"to",
"interfere",
"with",
"the",
"study",
"objectives",
"(",
"including",
"statins",
"or",
"medications",
"that",
"affect",
"hormones",
"[",
"e.g",
".",
"birth",
"control",
"pills",
"or",
"steroids",
"]",... | [
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
1,
0,
0
] |
NCT03112590 | 31:54:treatment,75:86:treatment,91:101:treatment | Must be candidates to receive paclitaxel chemotherapy in combination with trastuzumab and pertuzumab | 2 | [
"Must",
"be",
"candidates",
"to",
"receive",
"paclitaxel",
"chemotherapy",
"in",
"combination",
"with",
"trastuzumab",
"and",
"pertuzumab"
] | [
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
0,
1
] |
NCT03036098 | 44:57:treatment | Patients with disease that is suitable for local therapy administered | 2 | [
"Patients",
"with",
"disease",
"that",
"is",
"suitable",
"for",
"local",
"therapy",
"administered"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
1,
0
] |
NCT02323880 | 1:16:treatment,69:82:treatment,,132:146:treatment | Corticosteroids: If used to modify immune adverse events related to prior therapy, >= 14 days must have elapsed since last dose of corticosteroid | 2 | [
"Corticosteroids",
":",
"If",
"used",
"to",
"modify",
"immune",
"adverse",
"events",
"related",
"to",
"prior",
"therapy",
",",
">",
"=",
"14",
"days",
"must",
"have",
"elapsed",
"since",
"last",
"dose",
"of",
"corticosteroid"
] | [
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT03058029 | 12:18:cancer, | History of cancer within the past five(5) years | 2 | [
"History",
"of",
"cancer",
"within",
"the",
"past",
"five",
"(",
"5",
")",
"years"
] | [
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02498613 | 1:36:treatment | Prior treatment with anthracyclines | 2 | [
"Prior",
"treatment",
"with",
"anthracyclines"
] | [
1,
1,
1,
1
] |
NCT02349867 | 14:23:treatment,36:46:cancer,,99:117:treatment,121:141:cancer,145:180:cancer,189:204:cancer,218:233:cancer,240:256:treatment | Diagnosis or treatment for another malignancy within 3 years of enrollment, with the exception of complete resection of basal cell carcinoma or squamous cell carcinoma of the skin, any in situ malignancy, or low-risk prostate cancer after curative therapy | 2 | [
"Diagnosis",
"or",
"treatment",
"for",
"another",
"malignancy",
"within",
"3",
"years",
"of",
"enrollment",
",",
"with",
"the",
"exception",
"of",
"complete",
"resection",
"of",
"basal",
"cell",
"carcinoma",
"or",
"squamous",
"cell",
"carcinoma",
"of",
"the",
... | [
0,
0,
1,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
3,
3,
3,
0,
3,
3,
3,
3,
3,
3,
0,
0,
0,
3,
3,
0,
0,
0,
3,
3,
0,
1,
1
] |
NCT02312245 | 21:42:treatment,74:83:treatment,92:108:cancer | Receiving any other investigational agent which would be considered as a treatment for the primary neoplasm | 2 | [
"Receiving",
"any",
"other",
"investigational",
"agent",
"which",
"would",
"be",
"considered",
"as",
"a",
"treatment",
"for",
"the",
"primary",
"neoplasm"
] | [
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
0,
0,
3,
3
] |
NCT02159703 | 14:34:chronic_disease | Uncontrolled intercurrent illness | 2 | [
"Uncontrolled",
"intercurrent",
"illness"
] | [
0,
2,
2
] |
NCT01415882 | 1:14:treatment,24:44:treatment,56:66:treatment,70:81:treatment | Prior therapy with any proteasome inhibitor other than bortezomib or carfilzomib | 2 | [
"Prior",
"therapy",
"with",
"any",
"proteasome",
"inhibitor",
"other",
"than",
"bortezomib",
"or",
"carfilzomib"
] | [
1,
1,
0,
0,
1,
1,
0,
0,
1,
0,
1
] |
NCT01538966 | 31:41:chronic_disease,59:66:treatment,70:85:treatment | Newly diagnosed patients with acromegaly who have not had surgery or medical therapy | 2 | [
"Newly",
"diagnosed",
"patients",
"with",
"acromegaly",
"who",
"have",
"not",
"had",
"surgery",
"or",
"medical",
"therapy"
] | [
0,
0,
0,
0,
2,
0,
0,
0,
0,
1,
0,
1,
1
] |
NCT00291525 | 1:28:treatment | Concomitant cardiac surgery | 2 | [
"Concomitant",
"cardiac",
"surgery"
] | [
1,
1,
1
] |
NCT02544880 | 8:23:treatment,32:53:treatment,55:74:treatment,80:108:treatment, | Use of PDE5 inhibitors such as vardenafil (Levitra®), Tadalafil (Cialis®), and sildenafil citrate (Viagra®) ≤15-days prior to (intended) enrollment | 2 | [
"Use",
"of",
"PDE5",
"inhibitors",
"such",
"as",
"vardenafil",
"(",
"Levitra®",
")",
",",
"Tadalafil",
"(",
"Cialis®",
")",
",",
"and",
"sildenafil",
"citrate",
"(",
"Viagra®",
")",
"≤15-days",
"prior",
"to",
"(",
"intended",
")",
"enrollment"
] | [
0,
0,
1,
1,
0,
0,
1,
1,
0,
0,
0,
1,
1,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02462590 | 29:47:chronic_disease | primary diagnosis of severe acute pancreatitis, without reference to a Ranson score [Ranson 1974]) | 2 | [
"primary",
"diagnosis",
"of",
"severe",
"acute",
"pancreatitis",
",",
"without",
"reference",
"to",
"a",
"Ranson",
"score",
"[",
"Ranson",
"1974",
"]",
")"
] | [
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03119363 | 24:41:chronic_disease,80:86:chronic_disease,105:115:treatment,, | Confounding underlying medical illnesses which may cause fatigue (e.g., severe Anemia not controlled by medication, per self-report corroborated by medical chart review (e.g., Hb<10gm/dl) | 2 | [
"Confounding",
"underlying",
"medical",
"illnesses",
"which",
"may",
"cause",
"fatigue",
"(",
"e.g.",
",",
"severe",
"Anemia",
"not",
"controlled",
"by",
"medication",
",",
"per",
"self-report",
"corroborated",
"by",
"medical",
"chart",
"review",
"(",
"e.g.",
",... | [
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02857218 | 27:40:chronic_disease | Subjects with evidence of iron overload | 2 | [
"Subjects",
"with",
"evidence",
"of",
"iron",
"overload"
] | [
0,
0,
0,
0,
2,
2
] |
NCT02148003 | 41:56:chronic_disease | Subjects who have an active systemic or local infection | 2 | [
"Subjects",
"who",
"have",
"an",
"active",
"systemic",
"or",
"local",
"infection"
] | [
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT03136029 | 30:38:chronic_disease | These include a diagnosis of Dementia | 2 | [
"These",
"include",
"a",
"diagnosis",
"of",
"Dementia"
] | [
0,
0,
0,
0,
0,
2
] |
NCT02255383 | 1:21:chronic_disease,23:37:chronic_disease,39:58:chronic_disease,60:73:chronic_disease | rheumatoid arthritis, osteoarthritis, traumatic arthritis, polyarthritis | 2 | [
"rheumatoid",
"arthritis",
",",
"osteoarthritis",
",",
"traumatic",
"arthritis",
",",
"polyarthritis"
] | [
2,
2,
0,
2,
0,
2,
2,
0,
2
] |
NCT03175978 | 21:30:chronic_disease | Active uncontrolled infection or severe systemic infection (enrollment is possible after control of infection) | 2 | [
"Active",
"uncontrolled",
"infection",
"or",
"severe",
"systemic",
"infection",
"(",
"enrollment",
"is",
"possible",
"after",
"control",
"of",
"infection",
")"
] | [
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01943851 | 34:37:treatment | Otherwise, they must discontinue HRT to allow confirmation of post-menopausal status prior to study enrolment | 2 | [
"Otherwise",
",",
"they",
"must",
"discontinue",
"HRT",
"to",
"allow",
"confirmation",
"of",
"post-menopausal",
"status",
"prior",
"to",
"study",
"enrolment"
] | [
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02441101 | 1:28:chronic_disease, | Acute Myocardial infarction within 6 months of entry into the study | 2 | [
"Acute",
"Myocardial",
"infarction",
"within",
"6",
"months",
"of",
"entry",
"into",
"the",
"study"
] | [
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02456857 | 13:31:cancer | Presence of metastatic disease | 2 | [
"Presence",
"of",
"metastatic",
"disease"
] | [
0,
0,
3,
3
] |
NCT02360579 | 1:17:treatment,19:27:treatment,37:51:treatment | Targeted therapy: MEK/BRAF or other targeted agent | 2 | [
"Targeted",
"therapy",
":",
"MEK/BRAF",
"or",
"other",
"targeted",
"agent"
] | [
1,
1,
0,
1,
0,
0,
1,
1
] |
NCT02046395 | 12:28:cancer | History of multiple myeloma | 2 | [
"History",
"of",
"multiple",
"myeloma"
] | [
0,
0,
3,
3
] |
NCT02323880 | 21:51:cancer,122:134:treatment,195:216:treatment | Patients with known bone marrow metastatic disease will be eligible for study if they meet the blood counts (may receive transfusions provided they are not known to be refractory to red cell or platelet transfusions) | 2 | [
"Patients",
"with",
"known",
"bone",
"marrow",
"metastatic",
"disease",
"will",
"be",
"eligible",
"for",
"study",
"if",
"they",
"meet",
"the",
"blood",
"counts",
"(",
"may",
"receive",
"transfusions",
"provided",
"they",
"are",
"not",
"known",
"to",
"be",
"r... | [
0,
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0
] |
NCT02358187 | ,57:88:treatment,92:127:treatment,,170:207:treatment | Patients must be at least 3 weeks from the last dose of standard cytotoxic chemotherapy or myelosuppressive biological therapy and at least 1 week from the last dose of non-myelosuppressive biologic therapy | 2 | [
"Patients",
"must",
"be",
"at",
"least",
"3",
"weeks",
"from",
"the",
"last",
"dose",
"of",
"standard",
"cytotoxic",
"chemotherapy",
"or",
"myelosuppressive",
"biological",
"therapy",
"and",
"at",
"least",
"1",
"week",
"from",
"the",
"last",
"dose",
"of",
"n... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02064296 | 1:22:chronic_disease | Peripheral neuropathy of know cause that interferes with activities of daily living | 2 | [
"Peripheral",
"neuropathy",
"of",
"know",
"cause",
"that",
"interferes",
"with",
"activities",
"of",
"daily",
"living"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02233868 | 48:68:chronic_disease,159:174:treatment,192:221:treatment, | Current or past DSM-IV or DSM-5 diagnosis of a psychiatric disorder (other than alcohol in AD participants and nicotine/caffeine use disorders) that required hospitalization (any length), or chronic medication management (more than 4 weeks) and that could impact brain function at the time of the study as determined by ... | 2 | [
"Current",
"or",
"past",
"DSM-IV",
"or",
"DSM-5",
"diagnosis",
"of",
"a",
"psychiatric",
"disorder",
"(",
"other",
"than",
"alcohol",
"in",
"AD",
"participants",
"and",
"nicotine/caffeine",
"use",
"disorders",
")",
"that",
"required",
"hospitalization",
"(",
"an... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02382549 | 1:17:treatment,25:32:treatment,34:42:treatment,44:53:treatment,74:97:treatment | Inhaled steroids (e.g.: Advair®, Flovent®, Azmacort®) are not permitted. Topical corticosteroids are acceptable | 2 | [
"Inhaled",
"steroids",
"(",
"e.g",
".",
":",
"Advair®",
",",
"Flovent®",
",",
"Azmacort®",
")",
"are",
"not",
"permitted",
".",
"Topical",
"corticosteroids",
"are",
"acceptable"
] | [
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
NCT02473250 | 1:17:chronic_disease | blood dyscrasias | 2 | [
"blood",
"dyscrasias"
] | [
2,
2
] |
NCT02592707 | 65:89:treatment | Documentation of progressive disease based on RECIST v1.1 under prior anti-tumor therapy within 6 months of entry in the study (although the progression might have occurred more than 6 months before study entry) | 2 | [
"Documentation",
"of",
"progressive",
"disease",
"based",
"on",
"RECIST",
"v1.1",
"under",
"prior",
"anti-tumor",
"therapy",
"within",
"6",
"months",
"of",
"entry",
"in",
"the",
"study",
"(",
"although",
"the",
"progression",
"might",
"have",
"occurred",
"more",... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01419561 | 1:17:chronic_disease,, | Thrombocytopenia (platelets<100,000 cells/microL) | 2 | [
"Thrombocytopenia",
"(",
"platelets",
"<",
"100,000",
"cells/microL",
")"
] | [
2,
0,
0,
0,
0,
0,
0
] |
NCT02584309 | 7:10:chronic_disease,37:59:treatment,89:134:treatment | Known HIV-positivity on combination antiretroviral therapy because of the potential for pharmacokinetic interactions with dexrazoxane | 2 | [
"Known",
"HIV-positivity",
"on",
"combination",
"antiretroviral",
"therapy",
"because",
"of",
"the",
"potential",
"for",
"pharmacokinetic",
"interactions",
"with",
"dexrazoxane"
] | [
0,
2,
0,
0,
1,
1,
0,
0,
0,
0,
0,
1,
1,
1,
1
] |
NCT02819440 | 8:19:treatment, | Use of medications that strongly alter CYP3A4 activity | 2 | [
"Use",
"of",
"medications",
"that",
"strongly",
"alter",
"CYP3A4",
"activity"
] | [
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02320292 | 4:18:cancer | No leukemic phase | 2 | [
"No",
"leukemic",
"phase"
] | [
0,
3,
3
] |
NCT01639508 | 1:29:chronic_disease | gastrointestinal perforation | 2 | [
"gastrointestinal",
"perforation"
] | [
2,
2
] |
NCT02905188 | 1:14:chronic_disease,, | Heart failure of Class III-IV and / or C-D per NYHA Criteria | 2 | [
"Heart",
"failure",
"of",
"Class",
"III-IV",
"and",
"/",
"or",
"C-D",
"per",
"NYHA",
"Criteria"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01993719 | 18:21:chronic_disease,50:59:treatment,146:162:chronic_disease | Seronegative for HIV antibody. (The experimental treatment being evaluated in this protocol depends on an intact immune system. Patients who are HIV seropositive can have decreased immune-competence and thus are less responsive to the experimental treatment and more susceptible to its toxicities.) | 2 | [
"Seronegative",
"for",
"HIV",
"antibody",
".",
"(",
"The",
"experimental",
"treatment",
"being",
"evaluated",
"in",
"this",
"protocol",
"depends",
"on",
"an",
"intact",
"immune",
"system",
".",
"Patients",
"who",
"are",
"HIV",
"seropositive",
"can",
"have",
"d... | [
0,
0,
2,
2,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01130077 | 1:35:treatment | Allergy desensitization injections | 2 | [
"Allergy",
"desensitization",
"injections"
] | [
1,
1,
1
] |
NCT01802346 | 19:31:treatment | Concurrent use of somatostatin | 2 | [
"Concurrent",
"use",
"of",
"somatostatin"
] | [
0,
0,
0,
1
] |
NCT03080142 | 22:45:treatment | Patients on systemic anticoagulation therapy | 2 | [
"Patients",
"on",
"systemic",
"anticoagulation",
"therapy"
] | [
0,
0,
0,
1,
1
] |
NCT02583893 | 1:16:chronic_disease | unstable angina | 2 | [
"unstable",
"angina"
] | [
2,
2
] |
NCT02120222 | 1:29:chronic_disease, | gastrointestinal perforation within 28 days prior to beginning study treatment | 2 | [
"gastrointestinal",
"perforation",
"within",
"28",
"days",
"prior",
"to",
"beginning",
"study",
"treatment"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02423863 | 1:21:cancer,36:41:cancer,143:148:chronic_disease,177:196:treatment | Head and neck cancer patients with tumor invading major blood vessels for whom there may be a risk of blockage or bleeding if inflammation or edema is transiently increased by Hiltonol injections | 2 | [
"Head",
"and",
"neck",
"cancer",
"patients",
"with",
"tumor",
"invading",
"major",
"blood",
"vessels",
"for",
"whom",
"there",
"may",
"be",
"a",
"risk",
"of",
"blockage",
"or",
"bleeding",
"if",
"inflammation",
"or",
"edema",
"is",
"transiently",
"increased",
... | [
3,
3,
3,
3,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
1,
1
] |
NCT02719327 | 1:15:chronic_disease, | Claustrophobia requiring sedation for MRI | 2 | [
"Claustrophobia",
"requiring",
"sedation",
"for",
"MRI"
] | [
2,
0,
0,
0,
0
] |
NCT01750567 | ,63:74:treatment,76:88:treatment,90:97:treatment,99:106:treatment,108:120:treatment,125:146:treatment | Patients who relapse after receiving a one or more courses of fludarabine, bendamustine, cytoxan, rituxan, chlorambucil, or campath based therapy | 2 | [
"Patients",
"who",
"relapse",
"after",
"receiving",
"a",
"one",
"or",
"more",
"courses",
"of",
"fludarabine",
",",
"bendamustine",
",",
"cytoxan",
",",
"rituxan",
",",
"chlorambucil",
",",
"or",
"campath",
"based",
"therapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
0,
1,
1,
1
] |
NCT01627301 | 13:29:chronic_disease | any serious systemic disease | 2 | [
"any",
"serious",
"systemic",
"disease"
] | [
0,
0,
2,
2
] |
NCT02811263 | 20:34:chronic_disease | Sentinel event and encephalopathy occurred only after birth | 2 | [
"Sentinel",
"event",
"and",
"encephalopathy",
"occurred",
"only",
"after",
"birth"
] | [
0,
0,
0,
2,
0,
0,
0,
0
] |
NCT02496585 | 22:43:chronic_disease | Diagnosis of diffuse radiation pneumonitis | 2 | [
"Diagnosis",
"of",
"diffuse",
"radiation",
"pneumonitis"
] | [
0,
0,
0,
2,
2
] |
NCT02562716 | 20:38:chronic_disease | Patients must have measurable disease in the pancreas | 2 | [
"Patients",
"must",
"have",
"measurable",
"disease",
"in",
"the",
"pancreas"
] | [
0,
0,
0,
2,
2,
0,
0,
0
] |
NCT02441140 | 4:22:chronic_disease,36:64:cancer | No measurable disease or suspected Stage I or II ovarian cancer on preoperative imaging | 2 | [
"No",
"measurable",
"disease",
"or",
"suspected",
"Stage",
"I",
"or",
"II",
"ovarian",
"cancer",
"on",
"preoperative",
"imaging"
] | [
0,
2,
2,
0,
0,
3,
3,
3,
3,
3,
3,
0,
0,
0
] |
NCT00085982 | 56:71:treatment | The inclusion criteria should include any patient with extreme insulin resistance who has appropriately low leptin levels | 2 | [
"The",
"inclusion",
"criteria",
"should",
"include",
"any",
"patient",
"with",
"extreme",
"insulin",
"resistance",
"who",
"has",
"appropriately",
"low",
"leptin",
"levels"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT01696734 | 1:9:chronic_disease,11:19:chronic_disease,24:47:chronic_disease | valvular, ischemic, or pulmonary heart disease | 2 | [
"valvular",
",",
"ischemic",
",",
"or",
"pulmonary",
"heart",
"disease"
] | [
2,
0,
2,
0,
0,
2,
2,
2
] |
NCT00720785 | ,34:50:treatment,62:84:treatment,110:120:cancer | At least 4 weeks since any prior systemic therapy (excluding corticosteroid therapy) to treat the underlying malignancy (standard or investigational) | 2 | [
"At",
"least",
"4",
"weeks",
"since",
"any",
"prior",
"systemic",
"therapy",
"(",
"excluding",
"corticosteroid",
"therapy",
")",
"to",
"treat",
"the",
"underlying",
"malignancy",
"(",
"standard",
"or",
"investigational",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0
] |
NCT02446210 | 81:88:chronic_disease,128:142:treatment,144:153:treatment,158:183:treatment | Receiving drugs acting primarily on the central nervous system, which lower the seizure threshold such as antipsychotic drugs (chlorpromazine, clozapine) or tricyclic antidepressants | 2 | [
"Receiving",
"drugs",
"acting",
"primarily",
"on",
"the",
"central",
"nervous",
"system",
",",
"which",
"lower",
"the",
"seizure",
"threshold",
"such",
"as",
"antipsychotic",
"drugs",
"(",
"chlorpromazine",
",",
"clozapine",
")",
"or",
"tricyclic",
"antidepressant... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
1,
1
] |
NCT02769000 | 12:19:chronic_disease | History of seizure activity | 2 | [
"History",
"of",
"seizure",
"activity"
] | [
0,
0,
2,
0
] |
NCT00720785 | 19:28:chronic_disease | Ongoing or active infection | 2 | [
"Ongoing",
"or",
"active",
"infection"
] | [
0,
0,
0,
2
] |
NCT02162420 | 1:56:chronic_disease | Dyskeratosis Congenita (DC) with evidence of BM failure | 2 | [
"Dyskeratosis",
"Congenita",
"(",
"DC",
")",
"with",
"evidence",
"of",
"BM",
"failure"
] | [
2,
2,
2,
2,
2,
2,
2,
2,
0,
0
] |
NCT02695433 | 12:25:chronic_disease,27:38:chronic_disease,40:45:chronic_disease,47:63:chronic_disease,68:83:chronic_disease | history of heart disease, respiratory, renal, gastrointestinal, or hepatic disease | 2 | [
"history",
"of",
"heart",
"disease",
",",
"respiratory",
",",
"renal",
",",
"gastrointestinal",
",",
"or",
"hepatic",
"disease"
] | [
0,
0,
2,
2,
0,
2,
0,
2,
0,
2,
0,
0,
2,
2
] |
NCT02911467 | 13:29:chronic_disease,63:72:treatment,89:101:treatment | Patients on anti-coagulation they must be able to safely stop treatment for purposes of tumor biopsy | 2 | [
"Patients",
"on",
"anti-coagulation",
"they",
"must",
"be",
"able",
"to",
"safely",
"stop",
"treatment",
"for",
"purposes",
"of",
"tumor",
"biopsy"
] | [
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
1,
1
] |
NCT02203513 | ,133:160:treatment | Patients should have recurrent platinum-resistant - defined as disease recurrence by imaging within 6 months of the last receipt of platinum-based chemotherapy | 2 | [
"Patients",
"should",
"have",
"recurrent",
"platinum-resistant",
"-",
"defined",
"as",
"disease",
"recurrence",
"by",
"imaging",
"within",
"6",
"months",
"of",
"the",
"last",
"receipt",
"of",
"platinum-based",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02900794 | 1:23:chronic_disease | Chronic rhinosinusitis as described by the guidelines published in the 2015 Clinical practice guideline (update) | 2 | [
"Chronic",
"rhinosinusitis",
"as",
"described",
"by",
"the",
"guidelines",
"published",
"in",
"the",
"2015",
"Clinical",
"practice",
"guideline",
"(",
"update",
")"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03112174 | 26:29:cancer,230:270:treatment,275:306:treatment | Pathologically confirmed MCL (in tumor tissue), with documentation of either overexpression of cyclin D1 in association with other relevant markers (eg, CD19, CD20, PAX5, CD5) or evidence of t(11;14) as assessed by cytogenetics, fluorescent in situ hybridization (FISH), or polymerase chain reaction (PCR) | 2 | [
"Pathologically",
"confirmed",
"MCL",
"(",
"in",
"tumor",
"tissue",
")",
",",
"with",
"documentation",
"of",
"either",
"overexpression",
"of",
"cyclin",
"D1",
"in",
"association",
"with",
"other",
"relevant",
"markers",
"(",
"eg",
",",
"CD19",
",",
"CD20",
"... | [
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0
] |
NCT03038269 | 1:16:chronic_disease | Visual problems (uncorrected by glasses/contact lenses) | 2 | [
"Visual",
"problems",
"(",
"uncorrected",
"by",
"glasses/contact",
"lenses",
")"
] | [
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02339376 | 21:34:cancer | Rapidly progressive brain lesions | 2 | [
"Rapidly",
"progressive",
"brain",
"lesions"
] | [
0,
0,
3,
3
] |
NCT02947945 | 1:17:chronic_disease | Palpable purpura | 2 | [
"Palpable",
"purpura"
] | [
2,
2
] |
NCT02488967 | 8:23:chronic_disease | Active cardiac disease | 2 | [
"Active",
"cardiac",
"disease"
] | [
0,
2,
2
] |
NCT01445821 | 4:15:treatment,87:128:treatment,141:152:chronic_disease,161:199:treatment | On cardiac MRI, a diastolic septal bounce or diastolic septal flattering (D-sign), or diffuse myocardial gadolinium enhancement, or diffuse hypokinesis (patchy late gadolinium myocardial enhancement are not exclusion criteria) | 2 | [
"On",
"cardiac",
"MRI",
",",
"a",
"diastolic",
"septal",
"bounce",
"or",
"diastolic",
"septal",
"flattering",
"(",
"D-sign",
")",
",",
"or",
"diffuse",
"myocardial",
"gadolinium",
"enhancement",
",",
"or",
"diffuse",
"hypokinesis",
"(",
"patchy",
"late",
"gado... | [
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
2,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT02819141 | ,,104:112:treatment,114:127:treatment,129:137:treatment,139:147:treatment,149:158:treatment,160:168:treatment,170:179:treatment,181:189:treatment,191:202:treatment,204:219:treatment | received at least one intravenous bolus dose of a sedative/opioid medication in the previous 24 hours (fentanyl, hydromorphone, ketamine, morphine, midazolam, diazepam, lorazepam, propofol, haloperidol, dexmedetomidine) | 2 | [
"received",
"at",
"least",
"one",
"intravenous",
"bolus",
"dose",
"of",
"a",
"sedative/opioid",
"medication",
"in",
"the",
"previous",
"24",
"hours",
"(",
"fentanyl",
",",
"hydromorphone",
",",
"ketamine",
",",
"morphine",
",",
"midazolam",
",",
"diazepam",
",... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0
] |
NCT02013492 | 52:61:treatment | Patients may have had any number of prior systemic therapies | 2 | [
"Patients",
"may",
"have",
"had",
"any",
"number",
"of",
"prior",
"systemic",
"therapies"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01842399 | 1:13:treatment | Amphetamines | 2 | [
"Amphetamines"
] | [
1
] |
NCT01918683 | 8:16:chronic_disease, | Active GI bleed within 2 weeks of study enrollment | 2 | [
"Active",
"GI",
"bleed",
"within",
"2",
"weeks",
"of",
"study",
"enrollment"
] | [
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02370095 | 1:29:chronic_disease,,, | Severe chronic liver disease (Child-Pugh Score 11-15) | 2 | [
"Severe",
"chronic",
"liver",
"disease",
"(",
"Child-Pugh",
"Score",
"11-15",
")"
] | [
2,
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT01572480 | 1:14:treatment, | Immunoparesis with reduction of 2 uninvolved immunoglobulin isotypes | 2 | [
"Immunoparesis",
"with",
"reduction",
"of",
"2",
"uninvolved",
"immunoglobulin",
"isotypes"
] | [
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02632721 | 1:34:cancer | Acute promyelocytic leukemia (APL, French-American-British (FAB) subtype M3), according to WHO classification | 2 | [
"Acute",
"promyelocytic",
"leukemia",
"(",
"APL",
",",
"French-American-British",
"(",
"FAB",
")",
"subtype",
"M3",
")",
",",
"according",
"to",
"WHO",
"classification"
] | [
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02516670 | 6:29:chronic_disease | Have end stage renal disease | 2 | [
"Have",
"end",
"stage",
"renal",
"disease"
] | [
0,
2,
2,
2,
2
] |
NCT02516670 | 122:134:treatment | Patients who require frequent (several times a day) monitoring of their blood glucose or patients who have recently been hospitalized for glucose control | 2 | [
"Patients",
"who",
"require",
"frequent",
"(",
"several",
"times",
"a",
"day",
")",
"monitoring",
"of",
"their",
"blood",
"glucose",
"or",
"patients",
"who",
"have",
"recently",
"been",
"hospitalized",
"for",
"glucose",
"control"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT00338377 | 57:66:treatment, | Patients who have been previously treated with other IT therapies are eligible, as long as there is at least a 2 week wash out period | 2 | [
"Patients",
"who",
"have",
"been",
"previously",
"treated",
"with",
"other",
"IT",
"therapies",
"are",
"eligible",
",",
"as",
"long",
"as",
"there",
"is",
"at",
"least",
"a",
"2",
"week",
"wash",
"out",
"period"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.